Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer-Reference-Cited by-同舟云学术

Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer

Published:2016-08 Issue:5 Volume:16 Page:1273-1286
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Kurimchak Alison M.,Shelton Claude,Duncan Kelly E.,Johnson Katherine J.,Brown Jennifer,O’Brien Shane,Gabbasov Rashid,Fink Lauren S.,Li Yuesheng,Lounsbury Nicole,Abou-Gharbia Magid,Childers Wayne E.,Connolly Denise C.,Chernoff Jonathan,Peterson Jeffrey R.,Duncan James S.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference32 articles.

1. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3′ end processing;Ahn;Mol. Cell,2004

2. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity;Anastassiadis;Nat. Biotechnol.,2011

3. An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma;Baratta;Proc. Natl. Acad. Sci. USA,2015

4. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein;Bartholomeeusen;J. Biol. Chem.,2012

5. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer;Basbous;Mol. Cell. Biol.,2007

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells;Neoplasia;2024-11

2. The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors;2024-08-19

3. FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs;Nature Communications;2024-07-10

4. Defeating MYC with drug combinations or dual-targeting drugs;Trends in Pharmacological Sciences;2024-06

5. RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma;Scientific Reports;2024-04-23